These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31228528)

  • 1. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
    Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
    J Am Acad Dermatol; 2020 Jan; 82(1):72-79. PubMed ID: 31228528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized laboratory monitoring with use of isotretinoin in acne.
    Hansen TJ; Lucking S; Miller JJ; Kirby JS; Thiboutot DM; Zaenglein AL
    J Am Acad Dermatol; 2016 Aug; 75(2):323-8. PubMed ID: 27189824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
    Öktem A; Hayran Y; Arı E; Yalçın B
    J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
    Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
    JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Monitoring in Isotretinoin Therapy for Acne: How Long and How Often Must We Test Our Patients?
    Gonzalez M; Higham C; Janahi SA; McGee JS; Chung HJ
    Skinmed; 2024; 22(2):100-107. PubMed ID: 39089992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective evaluation of routine isotretinoin laboratory monitoring in patients older than 35 years.
    Sharma P; Tkachenko E; Mostaghimi A
    J Am Acad Dermatol; 2021 Jan; 84(1):201-202. PubMed ID: 32344069
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin.
    Tkachenko E; Sharma P; Mostaghimi A
    Dermatology; 2020; 236(6):517-520. PubMed ID: 32069457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Perspectives: Treating acne with isotretinoin.
    Pediatr Dermatol; 2015; 32(6):e324-5. PubMed ID: 26584707
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of isotretinoin on triglycerides and liver aminotransferases.
    Vieira AS; Beijamini V; Melchiors AC
    An Bras Dermatol; 2012; 87(3):382-7. PubMed ID: 22714752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile acne treated with oral isotretinoin.
    Miller IM; Echeverría B; Torrelo A; Jemec GB
    Pediatr Dermatol; 2013; 30(5):513-8. PubMed ID: 23278140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal liver function tests in acne patients receiving isotretinoin.
    Pona A; Cardenas-de la Garza JA; Haidari W; Cline A; Feldman SR; Taylor SL
    J Dermatolog Treat; 2021 Jun; 32(4):469-472. PubMed ID: 31498706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy.
    Choe J; Shields A; Ferreira A; Gold S; Gotschall JW; Kamal K; Rios A; Wang RH; Baumrin E; Dommasch ED; Yeung H; Lipoff JB; Barbieri JS
    JAMA Dermatol; 2024 Jul; 160(7):741-745. PubMed ID: 38809569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris.
    Altman RS; Altman LJ; Altman JS
    Dermatology; 2002; 204(3):232-5. PubMed ID: 12037453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
    Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
    J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
    Alcalay J; Landau M; Zucker A
    J Dermatolog Treat; 2001 Mar; 12(1):9-12. PubMed ID: 12171680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral isotretinoin on lipids and liver enzymes in acne patients.
    Kızılyel O; Metin MS; Elmas ÖF; Çayır Y; Aktaş A
    Cutis; 2014 Nov; 94(5):234-8. PubMed ID: 25474452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.